Corporate & Investor Presentation
Reconciliation of non-GAAP financial measures, cont'd
The measure "non-GAAP income from operations" is reconciled with GAAP income from operations below:
(Unaudited; $ in thousands, except for per share amounts)
Three Months Ended
March 31,
2022
March 31,
2021
Nine Months Ended
March 31,
2022
March 31,
2021
$
234,265 $
223,426 $
744,889 $
662,040
10,982
10,924
33,271
34,066
7,730
7,445
23,175
23,377
5,232
8,673
SA
252,977 $ 241,795 $
801,335
SA
$
733,388
GAAP income from operations
Amortization of acquired intangibles-cost of sales (A)
Amortization of acquired intangibles-operating
expenses (A)
Restructuring cost of sales (A)
Restructuring operating expenses
Non-GAAP income from operations
(A)
$
Note regarding non-GAAP reconciliations
ResMed adjusts for the impact of the amortization of acquired intangibles, reserve for disputed tax positions, restructuring expenses and the (gain) loss on equity investments from their evaluation of ongoing operations, and believes that investors
benefit from adjusting these items to facilitate a more meaningful evaluation of current operating performance.
ResMed believes that non-GAAP diluted earnings per share is an additional measure of performance that investors can use to compare operating results between reporting periods. ResMed uses non-GAAP information internally in planning,
forecasting, and evaluating the results of operations in the current period and in comparing it to past periods. ResMed believes this information provides investors better insight when evaluating ResMed's performance from core operations and
provides consistent financial reporting. The use of non-GAAP measures is intended to supplement, and not to replace, the presentation of net income and other GAAP measures. Like all non-GAAP measures, non-GAAP earnings are subject to
inherent limitations because they do not include all the expenses that must be included under GAAP.
36
© 2022 ResMed | Corporate & Investor Presentation - updated 28APR22
ResMedView entire presentation